On the Antibacterial Action of Cultures of a Penicillium, with Special Reference to their Use in the Isolation of B. influenzae, Br. J. Exp. Pathol, vol.10, pp.226-236, 1929. ,
Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis, Lancet Infect. Dis, vol.19, pp.56-66, 2019. ,
Achieving global targets for antimicrobial resistance, Science, vol.353, pp.874-875, 2016. ,
The World Health Assembly resolution on antimicrobial resistance, J. Antimicrob. Chemother, vol.69, pp.2883-2885, 2014. ,
The future of antibiotics and resistance, N. Engl. J. Med, vol.368, pp.299-302, 2013. ,
Tackling antibiotic resistance, Nat. Rev. Microbiol, vol.9, pp.894-896, 2011. ,
What is a resistance gene? Ranking risk in resistomes, Nat. Rev. Microbiol, vol.13, pp.116-123, 2015. ,
Nanotechnology solutions to restore antibiotic activity, J. Mater. Chem. B, vol.4, pp.824-833, 2016. ,
Why the antibiotic resistance crisis requires a One Health approach, Lancet Infect. Dis, vol.18, pp.132-134, 2018. ,
Nationwide survey of extended-spectrum ?-lactamase-producing Enterobacteriaceae in the French community setting, J. Antimicrob. Chemother, vol.63, pp.1205-1214, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00426312
Global epidemiology of CTX-M ?-lactamases: temporal and geographical shifts in genotype, J. Antimicrob. Chemother, vol.72, pp.2145-2155, 2017. ,
Inventory of Extended-Spectrum-?-Lactamase-Producing Enterobacteriaceae in France as Assessed by a Multicenter Study, Antimicrob. Agents Chemother, p.61, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01595458
An efficient system for intracellular delivery of beta-lactam antibiotics to overcome bacterial resistance, Sci. Rep, vol.5, p.13500, 2015. ,
In vivo efficacy of ?-lactam/tripropeptin C in a mouse septicemia model and the mechanism of reverse ?-lactam resistance in methicillin-resistant Staphylococcus aureus mediated by tripropeptin C, J. Antibiot. (Tokyo), vol.71, pp.79-85, 2018. ,
Antibiotics in the clinical pipeline at the end of 2015, J. Antibiot. (Tokyo), vol.70, pp.3-24, 2017. ,
Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?, Nat. Rev. Drug Discov, vol.14, pp.821-832, 2015. ,
Three Decades of -Lactamase Inhibitors, Clin. Microbiol. Rev, vol.23, pp.160-201, 2010. ,
CTX-M-190, a Novel ?-Lactamase Resistant to Tazobactam and Sulbactam, Identified in an Escherichia coli Clinical Isolate, Antimicrob. Agents Chemother, vol.61, pp.1848-1864, 2017. ,
Antisense oligonucleotides: from design to therapeutic application, Clin. Exp. Pharmacol. Physiol, vol.33, pp.533-540, 2006. ,
Translational Inhibition of CTX-M Extended Spectrum ?-Lactamase in Clinical Strains of Escherichia coli by Synthetic Antisense Oligonucleotides Partially Restores Sensitivity to, Cefotaxime. Front. Microbiol, vol.7, p.373, 2016. ,
Tetrahedral DNA Nanoparticle Vector for Intracellular Delivery of Targeted Peptide Nucleic Acid Antisense Agents to Restore Antibiotic Sensitivity in Cefotaxime-Resistant Escherichia coli, Nucleic Acid Ther, vol.27, pp.176-181, 2017. ,
Reversion of antibiotic resistance by inhibiting mecA in clinical methicillin-resistant Staphylococci by antisense phosphorothioate oligonucleotide, J. Antibiot. (Tokyo), vol.68, pp.158-164, 2015. ,
Bioconjugated Oligonucleotides: Recent Developments and Therapeutic Applications, Bioconjug. Chem, 2019. ,
Lipid-oligonucleotide conjugates improve cellular uptake and efficiency of TCTP-antisense in castration-resistant prostate cancer, J. Control. Release Off. J. Control. Release Soc, vol.258, pp.1-9, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-01520102
Advances in the delivery of antisense oligonucleotides for combating bacterial infectious diseases, Nanomedicine Nanotechnol. Biol. Med, vol.14, pp.745-758, 2018. ,
Interaction of nucleic acids with the glycocalyx, J. Am. Chem. Soc, vol.134, pp.6218-6223, 2012. ,
Sensitive liposomes encoded with oligonucleotide amphiphiles: a biocompatible switch, Chem. Commun, pp.5550-5552, 2008. ,
Controlling G-quadruplex formation via lipid modification of oligonucleotide sequences, Chem. Commun, vol.53, pp.11560-11563, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02475462
Lipid oligonucleotide conjugates as responsive nanomaterials for drug delivery, J. Mater. Chem. B, vol.1, p.5329, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-02484550
Lipid and Nucleic Acid Chemistries: Combining the Best of Both Worlds to Construct Advanced Biomaterials, Adv. Mater, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02374786
Nucleoside-Lipid-Based Nanocarriers for Sorafenib Delivery, Nanoscale Res. Lett, vol.13, p.17, 2018. ,
pH-Cleavable Nucleoside Lipids: A New Paradigm for Controlling the Stability of Lipid-Based Delivery Systems, ChemMedChem, vol.10, pp.1797-1801, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01543569
Efficient delivery of therapeutic small nucleic acids to prostate cancer cells using ketal nucleoside lipid nanoparticles, J. Control. Release Off. J. Control. Release Soc, vol.172, pp.954-961, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00975040
Lipid-Conjugated Oligonucleotides via "Click Chemistry" Efficiently Inhibit Hepatitis C Virus Translation, J. Med. Chem, vol.51, pp.4374-4376, 2008. ,
Quantum Dot Lipid Oligonucleotide Bioconjugates: Toward a New Anti-MicroRNA Nanoplatform, Bioconjug. Chem, vol.24, pp.1345-1355, 2013. ,
Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment, Saudi J. Biol. Sci, vol.22, pp.79-117, 1054. ,
Evaluation of ceftriaxone utilization in medical and emergency wards of Tikur Anbessa specialized hospital: a prospective cross-sectional study, BMC Pharmacol. Toxicol, vol.17, p.7, 2016. ,
Worldwide clinical experience with ceftriaxone, Chemotherapy, vol.35, pp.228-235, 1989. ,
Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK, J. Antimicrob. Chemother, vol.54, pp.735-743, 2004. ,
A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am, vol.49, pp.682-690, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00426315
Antibacterial resistance worldwide: causes, challenges and responses, Nat. Med, vol.10, pp.122-129, 2004. ,
The impact of antibiotic use on resistance development and persistence, Drug Resist. Updat. Rev. Comment. Antimicrob. Anticancer Chemother, vol.3, pp.303-311, 2000. ,
Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy, Nat. Chem. Biol, vol.7, pp.348-350, 2011. ,
Antibiotic resistance: lessons for the future, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am, vol.27, issue.1, 1998. ,
Nanotechnology as a therapeutic tool to combat microbial resistance, Adv. Drug Deliv. Rev, vol.65, pp.1803-1815, 2013. ,
Nano-technology for targeted drug delivery to combat antibiotic resistance, Expert Opin. Drug Deliv, vol.9, pp.1325-1332, 2012. ,
Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections, Int. J. Antimicrob. Agents, vol.43, pp.485-496, 2014. ,
Nanoformulated antibiotics: the next step for pathogenic bacteria control, Curr. Med. Chem, vol.20, pp.1232-1240, 2013. ,
Nanoantibiotics': a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era, J. Control. Release Off. J. Control. Release Soc, vol.156, pp.128-145, 2011. ,
, Guidance documents. Société Française de Microbiologie, 2019.